Beyond Air has been given an innovative technology contract from Vizient for its…
Articles by Marisa Wexler, MS
Endotronix has been cleared by U.S. regulators to launch a clinical trial testing its Cordella Sensor, an implanted…
The U.S. Food and Drug Administration (FDA) has agreed to review an application seeking approval of sotatercept as a treatment…
Note: This story was updated Jan. 30, 2024, to correct the approved indications of available treprostinil formulations. Amid ongoing…
Treatment with VU6047534, an experimental therapy that blocks the activity of a specific type of serotonin receptor, reduced strain on…
Treatment with sotatercept in addition to standard pulmonary arterial hypertension (PAH) therapies significantly improved measures of heart health for…
A Phase 3 clinical trial testing high-dose Opsumit (macitentan) in people with chronic thromboembolic pulmonary hypertension (CTEPH) has…
The protein LTBP1 is active at high levels in pulmonary arterial hypertension (PAH) and may be a diagnostic marker…
Psychological counseling and therapy are among the interventions that may help adults with pulmonary hypertension (PH) manage depression and…
Tenax Therapeutics has been issued a U.S. patent covering oral levosimendan, also known as TNX-103, for the treatment…
Liquidia has licensed the rights in North America to L606, a novel inhaled formulation of treprostinil that’s being tested…
Janssen Pharmaceuticals has submitted an application in Europe asking regulatory authorities to approve the company’s combination therapy of macitentan…